Summit Trail Advisors’s Qiagen QGEN Stock Holding History

Summit Trail Advisors’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$723K	Buy	18,625 +4,897	+36%	+$182K	0.01%	1102
2026 Q1	$550K	Sell	13,728 -436	-3%	-$20.6K	0.01%	1141
2025 Q4	$641K	Buy	14,164 +2,568	+22%	+$119K	0.01%	1007
2025 Q3	$516K	Buy	+11,596	New	+$555K	0.01%	1073
2018 Q1	–	Sell	-1,441	Closed	-$51K	–	1360
2017 Q4	$51K	Buy	+1,441	New	+$49.7K	0.01%	813

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Summit Trail Advisors's QGEN Position: Q2 2026 in Review

Summit Trail Advisors increased its Qiagen (QGEN) stake by 36% in Q2 2026, buying an estimated $182K and bringing the position to 18,625 shares worth $723K. The position accounts for 0.01% of the portfolio, ranked #1102.

Summit Trail Advisors first reported a position in QGEN in Q4 2017 and has held it in 5 quarters since. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

Summit Trail Advisors held 18,625 shares of Qiagen worth $723K as of Q2 2026.
Summit Trail Advisors bought 4,897 Qiagen shares in Q2 2026, an estimated $182K.
Qiagen made up 0.01% of Summit Trail Advisors's portfolio in Q2 2026, its #1102 holding.
Summit Trail Advisors first reported a position in Qiagen in Q4 2017 and has held it in 5 quarters since.
336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.